Cargando…

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports

Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez, Ana Victoria Carro, Chiva, Lydia Montolio, Villarino, Montserrat Robustillo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575172/ https://www.ncbi.nlm.nih.gov/pubmed/34804171 http://dx.doi.org/10.7573/dic.2021-8-5

Ejemplares similares

Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats
por: Ma, Shuai, et al.
Publicado: (2017)

Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022)

Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
por: Fujii, Asami, et al.
Publicado: (2017)

Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020)

Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
por: de Carpi, Javier Martin
Publicado: (2022)

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)

Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017)

Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
por: Lai, Ya-Min, et al.
Publicado: (2017)

Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
por: Yanagisawa, Kazuki, et al.
Publicado: (2019)

Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
por: Kanekura, Takuro, et al.
Publicado: (2020)

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease
por: Lindberg, Annelie, et al.
Publicado: (2010)

Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults
por: Kaneko, Shuzo, et al.
Publicado: (2023)

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
por: Nakamura, Masanao, et al.
Publicado: (2020)

Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
por: Motoya, Satoshi, et al.
Publicado: (2019)

Peripheral Blood CD64 Levels Decrease in Crohn's Disease following Granulocyte and Monocyte Adsorptive Apheresis
por: Chiba, Toshimi, et al.
Publicado: (2011)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2021)

Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2020)

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
por: Koroku, Miki, et al.
Publicado: (2022)

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
por: Yoshimura, Naoki, et al.
Publicado: (2015)

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
por: Yokoyama, Yoko, et al.
Publicado: (2013)

Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
por: Imperiali, Gianni, et al.
Publicado: (2017)

Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
por: Ozeki, Keiji, et al.
Publicado: (2012)

Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study
por: Yamamoto, Takayuki, et al.
Publicado: (2016)

Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis in a Patient with Low Bone Mineral Density Due to Fanconi-Bickel Syndrome
por: Tanaka, Makoto, et al.
Publicado: (2021)

Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis
por: Kiss, Szabolcs, et al.
Publicado: (2021)

Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection()
por: Robustillo-Villarino, Montserrat, et al.
Publicado: (2022)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

Granulocyte-Macrophage Colony-Stimulating Factor-Activated Monocytes as an Anti-inflammatory Player in the Intestine
por: Viennois, Emilie, et al.
Publicado: (2015)

Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease
por: Fukuchi, Takumi, et al.
Publicado: (2014)

Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial
por: Fukunaga, Ken, et al.
Publicado: (2012)

A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
por: Tominaga, Chiharu, et al.
Publicado: (2015)

Immunophenotyping monocytes, macrophages and granulocytes in the Pteropodid bat Eonycteris spelaea
por: Gamage, Akshamal M., et al.
Publicado: (2020)

Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
por: Ueno, Nobuhiro, et al.
Publicado: (2021)

Infliximab- and Immunosuppressant-Resistant Crohn's Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone
por: Itagaki, Munenori, et al.
Publicado: (2012)

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results
por: Dignass, Axel, et al.
Publicado: (2016)

Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial
por: Kakimoto, Kazuki, et al.
Publicado: (2020)

Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma
por: Erriah, Melanie, et al.
Publicado: (2019)

Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor
por: Tanida, Satoshi, et al.
Publicado: (2023)

Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
por: Mastronardi, Mauro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7g2luuhu1ibekun1c8adru71mn